AIM: To develop a patient-based Simple Clinical Colitis Activity Index (P-SCCAI) of ulcerative colitis (UC) activity and to compare it with the clinician-based SCCAI, C-reactive protein (CRP) and Physician's Global Assessment (PGA) of UC activity. Monitoring UC activity may give patients disease control and prevent unnecessary examinations. METHODS: Consecutive UC patients randomly completed the P-SCCAI either before or after consultation. Gastroenterologists assessed patients' UC activity on the same day. Overall agreement between SCCAI and P-SCCAI was calculated with Spearman's Rho and Mann-Whitney U test. Agreement regarding active disease versus remission and agreement at domain level were calculated by percent agreement and kappa (κ). RESULTS: 149 (response rate 84.7%) UC patients participated. P-SCCAI and SCCAI showed a large correlation (rs=0.79). The medians (IQR) of the P-SCCAI (3.78;0-15) tended to be higher than those of the SCCAI (2.86;0-13), although this difference did not reach statistical significance (z=1.71| p=0.088). In 77% of the cases the difference between clinicians' and patients' scores was not clinically different (i.e.≤2). Percentage agreement between clinicians and patients, judging UC as active or in remission, was 87%, rs=0.66, κ=0.66, indicating a substantial agreement. In general patients tended to report more physical symptoms than clinicians. C-Reactive protein (CRP) was found to have a significant association with both P-SCCAI and SCCAI (κ=0.32, κ=0.39 respectively) as was PGA (κ=0.73 for both indices). CONCLUSIONS: The P-SCCAI is a promising tool given its substantial agreement with the SCCAI and its feasibility. Therefore, P-SCCAI can complement SCCAI in clinical care and research.
AIM: To develop a patient-based Simple Clinical Colitis Activity Index (P-SCCAI) of ulcerative colitis (UC) activity and to compare it with the clinician-based SCCAI, C-reactive protein (CRP) and Physician's Global Assessment (PGA) of UC activity. Monitoring UC activity may give patients disease control and prevent unnecessary examinations. METHODS: Consecutive UC patients randomly completed the P-SCCAI either before or after consultation. Gastroenterologists assessed patients' UC activity on the same day. Overall agreement between SCCAI and P-SCCAI was calculated with Spearman's Rho and Mann-Whitney U test. Agreement regarding active disease versus remission and agreement at domain level were calculated by percent agreement and kappa (κ). RESULTS: 149 (response rate 84.7%) UC patients participated. P-SCCAI and SCCAI showed a large correlation (rs=0.79). The medians (IQR) of the P-SCCAI (3.78;0-15) tended to be higher than those of the SCCAI (2.86;0-13), although this difference did not reach statistical significance (z=1.71| p=0.088). In 77% of the cases the difference between clinicians' and patients' scores was not clinically different (i.e.≤2). Percentage agreement between clinicians and patients, judging UC as active or in remission, was 87%, rs=0.66, κ=0.66, indicating a substantial agreement. In general patients tended to report more physical symptoms than clinicians. C-Reactive protein (CRP) was found to have a significant association with both P-SCCAI and SCCAI (κ=0.32, κ=0.39 respectively) as was PGA (κ=0.73 for both indices). CONCLUSIONS: The P-SCCAI is a promising tool given its substantial agreement with the SCCAI and its feasibility. Therefore, P-SCCAI can complement SCCAI in clinical care and research.
Authors: Vineet S Rolston; Laleh Boroujerdi; Millie D Long; Dermot P B McGovern; Wenli Chen; Christopher F Martin; Robert S Sandler; John D Carmichael; Marla Dubinsky; Gil Y Melmed Journal: Inflamm Bowel Dis Date: 2018-01-18 Impact factor: 5.325
Authors: Orly Sarid; Vered Slonim-Nevo; Doron Schwartz; Michael Friger; Ruslan Sergienko; Avihu Pereg; Hillel Vardi; Elena Chernin; Terri Singer; Dan Greenberg; Shmuel Odes Journal: Int J Behav Med Date: 2018-06
Authors: Tiffany H Taft; Alyse Bedell; Meredith R Craven; Livia Guadagnoli; Sarah Quinton; Stephen B Hanauer Journal: Inflamm Bowel Dis Date: 2019-08-20 Impact factor: 5.325
Authors: Animesh Jain; Nghia H Nguyen; James A Proudfoot; Christopher F Martin; William J Sandborn; Michael D Kappelman; Millie D Long; Siddharth Singh Journal: Am J Gastroenterol Date: 2019-04 Impact factor: 10.864
Authors: Mike van der Have; Bas Oldenburg; Ad A Kaptein; Jeroen M Jansen; Robert C H Scheffer; Bas A van Tuyl; Andrea E van der Meulen-de Jong; Marieke Pierik; Peter D Siersema; Martijn G H van Oijen; Herma H Fidder Journal: J Crohns Colitis Date: 2016-01-06 Impact factor: 9.071
Authors: Marc A Ward; Joseph F Pierre; Raquel F Leal; Yong Huang; Benjamin Shogan; Sushila R Dalal; Christopher R Weber; Vanessa A Leone; Mark W Musch; Gary C An; Mrinalini C Rao; David T Rubin; Laura E Raffals; Dionysios A Antonopoulos; Mitch L Sogin; Neil H Hyman; John C Alverdy; Eugene B Chang Journal: Am J Physiol Gastrointest Liver Physiol Date: 2016-04-14 Impact factor: 4.052
Authors: Floor Bennebroek Evertsz'; Claudi L H Bockting; Pieter C F Stokkers; Chris Hinnen; Robbert Sanderman; Mirjam A G Sprangers Journal: BMC Psychiatry Date: 2012-12-14 Impact factor: 3.630